The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.

The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction. Blood Press. 2019 Jun 11;:1-2 Authors: Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S PMID: 31184508 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31184508?dopt=Abstract

Source: Blood Pressure - June 13, 2019 Category: Hematology Tags: Blood Press Source Type: research